Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
medium and long chain fat emulsion
- Development stage
- Unknown
- Lead developer
- Guangdong Jiabo Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
Medium and long chain fat emulsion (C8-24Ve) is an intravenous lipid emulsion used in parenteral nutrition to provide energy and essential fatty acids to patients who are unable to receive adequate nutrition through oral or enteral routes. It is a physical mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT, typically derived from soybean oil), enriched with alpha-tocopherol (Vitamin E) to enhance oxidative stability and reduce lipid peroxidation. MCTs are rapidly cleared from the bloodstream and oxidized to provide quick energy, while LCTs supply essential fatty acids to prevent deficiency. The formulation was originally developed by B. Braun (marketed as Lipofundin MCT/LCT) and is also manufactured and developed by Guangdong Jiabo Pharmaceutical and Guangdong Jibao Pharmaceutical Technology.
- Brand names
- LipofundinLipofundin MCT/LCT力保肪宁
- Other names
- C8-24VEC-8-24VEC 8-24VEMCT/LCT Fat Emulsion InjectionMCT/LCT Fat Emulsion Injection (C8-24VE)medium and long chain fat emulsionmedium and long chain fat emulsion (C8-24Ve)medium and long chain fat emulsion injection (C8-24Ve)
02
Targets
KATP channel (ATP-sensitive potassium channel)NOS3 (eNOS)sGC (Soluble Guanylyl Cyclase)
Beyond the preview
Go deeper on medium and long chain fat emulsion.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on medium and long chain fat emulsion.